HRP20200630T1 - Triazini, namijenjeni liječenju protozojskih bolesti - Google Patents

Triazini, namijenjeni liječenju protozojskih bolesti Download PDF

Info

Publication number
HRP20200630T1
HRP20200630T1 HRP20200630TT HRP20200630T HRP20200630T1 HR P20200630 T1 HRP20200630 T1 HR P20200630T1 HR P20200630T T HRP20200630T T HR P20200630TT HR P20200630 T HRP20200630 T HR P20200630T HR P20200630 T1 HRP20200630 T1 HR P20200630T1
Authority
HR
Croatia
Prior art keywords
preparation
pig
intended
administered
accordance
Prior art date
Application number
HRP20200630TT
Other languages
English (en)
Inventor
Hamadi Karembe
Roman Krejci
Jérôme GUYONNET
Hannelie Cilliers
Original Assignee
CEVA Santé Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47351540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20200630(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by CEVA Santé Animale SA filed Critical CEVA Santé Animale SA
Publication of HRP20200630T1 publication Critical patent/HRP20200630T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Dispersion Chemistry (AREA)

Claims (7)

1. Pripravak, koji sadrži toltrazuril i kompleks željeza, koji je vodena koloidna otopina β-feri oksihidroksida i dekstranglukoheptonske kiseline, naznačen time što je namijenjen upotrebi u liječenju kokcidioze kod prasadi, gdje se navedeni pripravak primjenjuje intramuskularnom injekcijom.
2. Pripravak namijenjen upotrebi u skladu s patentnim zahtjevom 1, naznačen time što se pripravak primjenjuje jednom injekcijom na prasetu.
3. Pripravak namijenjen upotrebi u skladu s patentnim zahtjevom 1 ili 2, naznačen time što se pripravak primjenjuje intramuskularnom injekcijom u vrat ili iza uha praseta.
4. Pripravak namijenjen upotrebi u skladu s patentnim zahtjevom 1, naznačen time što sadrži između 1 i 60 mg toltrazurila po kg tjelesne težine.
5. Pripravak namijenjen upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 do 4, naznačen time što je formulacija suspenzija.
6. Pripravak namijenjen upotrebi u preventivnom liječenju praseta od kokcidioze, naznačen time što je pripravak suspenzija koja sadrži između 1 i 60 mg toltrazurila i kompleksa željeza, koji je vodena koloidna otopina beta-feri oksihidroksida i dekstranglukoheptonske kiseline, te što se pripravak primjenjuje intramuskularnom injekcijom na navedenom prasetu.
7. Pripravak namijenjen upotrebi u skladu s patentnim zahtjevom 1 ili 6, naznačen time što je prase novorođeno do 10 dana staro prase.
HRP20200630TT 2012-12-07 2020-04-15 Triazini, namijenjeni liječenju protozojskih bolesti HRP20200630T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306546.8A EP2740469A1 (en) 2012-12-07 2012-12-07 New treatments with triazines
EP13802596.0A EP2928454B1 (en) 2012-12-07 2013-12-06 Triazines for treating protozoan diseases
PCT/EP2013/075755 WO2014086958A1 (en) 2012-12-07 2013-12-06 New treatments with triazines

Publications (1)

Publication Number Publication Date
HRP20200630T1 true HRP20200630T1 (hr) 2020-07-10

Family

ID=47351540

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200630TT HRP20200630T1 (hr) 2012-12-07 2020-04-15 Triazini, namijenjeni liječenju protozojskih bolesti

Country Status (23)

Country Link
US (1) US9877969B2 (hr)
EP (3) EP2740469A1 (hr)
JP (1) JP6125034B2 (hr)
KR (1) KR102253497B1 (hr)
CN (3) CN113144202A (hr)
AU (1) AU2013353982B2 (hr)
BR (3) BR122021005311B1 (hr)
CA (1) CA2892886C (hr)
CL (1) CL2015001563A1 (hr)
CY (1) CY1123190T1 (hr)
DK (1) DK2928454T3 (hr)
ES (1) ES2778950T3 (hr)
FR (1) FR20C1044I2 (hr)
HR (1) HRP20200630T1 (hr)
HU (2) HUE049950T2 (hr)
MX (1) MX2015007128A (hr)
NL (1) NL301064I2 (hr)
PH (1) PH12015501220B1 (hr)
PL (1) PL2928454T3 (hr)
PT (1) PT2928454T (hr)
RU (1) RU2696265C2 (hr)
SI (1) SI2928454T1 (hr)
WO (1) WO2014086958A1 (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4493826A (en) * 1982-01-25 1985-01-15 Schering Corporation Gentamicin-gleptoferron compositions
US5219853A (en) 1983-01-12 1993-06-15 Bayer Aktiengesellschaft Agent for coccidiosis
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DE19603954C2 (de) 1996-02-05 2003-04-17 Wagon Automotive Gmbh Prallträger für ein Kraftfahrzeug
DE19603984A1 (de) 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
BR9914385A (pt) * 1998-10-08 2001-07-17 New Ace Res Company Composição útil para o tratamento e prevenção de infecções protozoárias no homem e em animais, e, método de tratamento de uma infecção protozoária no homem e em animais
WO2001026660A1 (en) 1999-10-08 2001-04-19 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DK2532378T3 (en) 2004-12-01 2016-07-25 Acushot Inc needleless injector
AU2007257173B2 (en) 2006-06-07 2013-03-14 Acushot Inc. Charging mechanism for a needle-free injector
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
US20110288521A1 (en) 2008-03-07 2011-11-24 Pharma Jet ,Inc. Intradermal injector and uses thereof
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
FR2946882B1 (fr) 2009-06-18 2011-08-26 Ceva Sante Animale Suspension veterinaire gelifiee de fer
CN101947201B (zh) 2010-09-08 2011-12-28 洛阳惠中兽药有限公司 兽药纳米混悬剂及其制备方法与应用
CN102512366A (zh) 2011-12-28 2012-06-27 广州市和生堂动物药业有限公司 妥曲珠利悬浮乳剂及其制备方法
CN102743334A (zh) 2012-07-30 2012-10-24 郑州后羿制药有限公司 一种妥曲珠利注射剂及其制备方法
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies

Also Published As

Publication number Publication date
WO2014086958A1 (en) 2014-06-12
NL301064I2 (nl) 2021-03-03
AU2013353982A1 (en) 2015-06-11
RU2696265C2 (ru) 2019-08-01
PL2928454T3 (pl) 2020-08-24
CL2015001563A1 (es) 2015-10-23
PH12015501220A1 (en) 2015-08-17
JP2016501252A (ja) 2016-01-18
PT2928454T (pt) 2020-04-23
HUE049950T2 (hu) 2020-11-30
HUS2000037I1 (hu) 2020-10-28
BR122021005310B1 (pt) 2022-01-25
FR20C1044I2 (fr) 2021-10-15
SI2928454T1 (sl) 2020-07-31
BR112015013182A2 (pt) 2017-07-11
EP2928454B1 (en) 2020-03-18
KR20150104565A (ko) 2015-09-15
PH12015501220B1 (en) 2015-08-17
US9877969B2 (en) 2018-01-30
FR20C1044I1 (hr) 2020-10-30
CN113144202A (zh) 2021-07-23
RU2015127025A (ru) 2017-01-12
CA2892886C (en) 2021-09-07
JP6125034B2 (ja) 2017-05-10
CA2892886A1 (en) 2014-06-12
EP2740469A1 (en) 2014-06-11
EP3721869A1 (en) 2020-10-14
AU2013353982B2 (en) 2018-01-04
KR102253497B1 (ko) 2021-05-21
BR122021005311B1 (pt) 2022-01-25
US20150313905A1 (en) 2015-11-05
MX2015007128A (es) 2015-10-14
CN104981233A (zh) 2015-10-14
DK2928454T3 (da) 2020-03-30
ES2778950T3 (es) 2020-08-12
CN112370454A (zh) 2021-02-19
EP2928454A1 (en) 2015-10-14
CY1123190T1 (el) 2021-10-29

Similar Documents

Publication Publication Date Title
HRP20200630T1 (hr) Triazini, namijenjeni liječenju protozojskih bolesti
HRP20171256T1 (hr) Farmaceutski pripravci karbetocina
HRP20200777T1 (hr) Formulacije koje sadrže triazinone i željezo
RU2020111176A (ru) Лечение кокцидиоза внутримышечными композициями триазина
PH12018500044A1 (en) Stuffy nose deblocking composition having antiviral activity
EP3238724A3 (en) Chemical suppressors of neurotoxicity in synucleinopathic diseases
WO2014052780A3 (en) Compositions and methods of use of an inappetance-controlling compound
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
WO2016154542A3 (en) Compositions and methods for treating cardiovascular related disorders
CN102860324A (zh) 一种家庭环境清洗消毒剂
BR112015003733A2 (pt) composições de liberação estendida de um nitrato de aminoalquila
WO2013150463A3 (en) Animal harness
HRP20211696T1 (hr) Postupak izrade fluoriranih olefina
MX2019002386A (es) Uso de oligosacaridos de leche humana en el engorde de terneros.
MX2018010858A (es) Particulas de liberacion de farmacos.
CN103610210A (zh) 含有吸水树脂的食品保鲜剂
MX2015014634A (es) Golosina comestible de juego para animales de compañia.
Jung et al. Diving dynamics of seabirds
PH12014502014A1 (en) Animal feed composition containing encapsulated glucono delta-lactone
Abramova Embryotropic properties of ricazole.
Minasyan et al. Using of suiferrovit-A as a pathogenic agent in bovine anaplasmosis
Гридюшко et al. Reproductive traits of pigs of the Belarusian plant type of Yorkshire breed of pigs
Terentyeva et al. Aminotransferases in tissues of in piglets cecum
UA103328U (uk) Спосіб підвищення загальної резистентності поросят та продуктивності свиней
Pivtorak et al. Use of mineral feed additive in silage-pulp fattening young cattle